Lutge EE, Gray A, Siegfried N (April 2013). „The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS”. The Cochrane Database of Systematic Reviews (Review). 4 (4): CD005175. doi:10.1002/14651858.CD005175.pub3. PMID 23633327.
D’SouzaD.’S.DCD’SouzaD.’S., SewellS.RASewellS., RanganathanR.MRanganathanR., Cannabis and psychosis/schizophrenia: human studies, „European Archives of Psychiatry and Clinical Neuroscience”, 259 (7), 2009, s. 413–31, DOI: 10.1007/s00406-009-0024-2, PMID: 19609589, PMCID: PMC2864503.
CrippaC.JACrippaC. i inni, Cannabis and anxiety: a critical review of the evidence, „Human Psychopharmacology”, 24 (7), 2009, s. 515–23, DOI: 10.1002/hup.1048, PMID: 19693792.
F MarkusF.M.LewekeF MarkusF.M. i inni, Therapeutic Potential of Cannabinoids in Psychosis, „Biological Psychiatry”, 79 (7), 2016, s. 604–12, DOI: 10.1016/j.biopsych.2015.11.018, PMID: 26852073, Cytat: Epidemiological data indicate a strong relationship between cannabis use and psychosis and schizophrenia beyond transient intoxication with an increased risk of any psychotic outcome in individuals who had ever used cannabis.
MBM.Ortiz-MedinaMBM. i inni, Cannabis consumption and psychosis or schizophrenia development, „The International Journal of Social Psychiatry”, 64 (7), 2018, s. 690–704, DOI: 10.1177/0020764018801690, PMID: 30442059, Cytat: Cannabis use doubles the risk of developing psychosis in vulnerable people..
CharlesCh.KsirCharlesCh., Carl L.C.L.HartCarl L.C.L., Cannabis and Psychosis: a Critical Overview of the Relationship, „Current Psychiatry Reports”, 18 (2), 2016, s. 12, DOI: 10.1007/s11920-015-0657-y, PMID: 26781550.
StefanS.HartStefanS., Oliver M.O.M.FischerOliver M.O.M., AxelA.UllrichAxelA., Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor., „Cancer Research”, 64 (6), 2004, DOI: 10.1158/0008-5472.can-03-3720, PMID: 15026328 [dostęp 2020-04-16].
GabriellaG.AvielloGabriellaG. i inni, Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer., „Journal of Molecular Medicine”, 90 (8), US National Library of Medicine. National Institutes of Health, 2012, s. 925–934, DOI: 10.1007/s00109-011-0856-x, PMID: 22231745 [dostęp 2013-02-20](ang.).
Jeremy R.J.R.JohnsonJeremy R.J.R. i inni, An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics, „Journal of Pain and Symptom Management”, 46 (2), 2013, s. 207–218, DOI: 10.1016/j.jpainsymman.2012.07.014, ISSN1873-6513, PMID: 23141881, OCLC818882612.
Shaheen ES.E.LakhanShaheen ES.E., MarieM.RowlandMarieM., Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review, „BMC Neurology”, 9 (59), 2009, DOI: 10.1186/1471-2377-9-59, PMID: 19961570, PMCID: PMC2793241.
Barbara S.B.S.KoppelBarbara S.B.S. i inni, Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology, „Neurology”, 82 (17), 2014, s. 1556–1563, DOI: 10.1212/WNL.0000000000000363, ISSN1526-632X, PMID: 24778283, PMCID: PMC4011465, OCLC960771045.
Amir H.A.H.SamAmir H.A.H., VictoriaV.SalemVictoriaV., Mohammad A.M.A.GhateiMohammad A.M.A., Rimonabant: From RIO to Ban, „Journal of Obesity”, 2011, DOI: 10.1155/2011/432607, PMID: 21773005, PMCID: PMC3136184 [dostęp 2020-04-15].
RafaelR.MaldonadoRafaelR., OlgaO.ValverdeOlgaO., Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses, „European Neuropsychopharmacology”, 13 (6), 2003, s. 401–410, DOI: 10.1016/j.euroneuro.2003.08.001, PMID: 14636956.
J.E.J.E.ThistleJ.E.J.E. i inni, Marijuana use and serum testosterone concentrations among U.S. males, „Andrology”, 5 (4), 2017, s. 732–738, DOI: 10.1111/andr.12358, PMID: 28395129, PMCID: PMC5660879(ang.).
DaleD.GieringerDaleD., Joseph St.J.S.LaurentJoseph St.J.S., ScottS.GoodrichScottS., Cannabis Vaporizer Combines Efficient Delivery of THC with Effective Suppression of Pyrolytic Compounds, „Journal of Cannabis Therapeutics”, 4 (1), 2004, s. 7–27, DOI: 10.1300/J175v04n01_02(ang.).
HaroldH.KalantHaroldH., Adverse effects of cannabis on health: an update of the literature since 1996, „Progress in Neuro-Psychopharmacology & Biological Psychiatry”, 28 (5), 2004, s. 849–863, DOI: 10.1016/j.pnpbp.2004.05.027, PMID: 15363608.
S.H.S.H.BarskyS.H.S.H. i inni, Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco, „Journal of the National Cancer Institute”, 90 (16), 1998, s. 1198–1205, DOI: 10.1093/jnci/90.16.1198, PMID: 9719080.
Li RitaL.R.ZhangLi RitaL.R. i inni, Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium, „International Journal of Cancer”, 136 (4), 2015, s. 894–903, DOI: 10.1002/ijc.29036, PMID: 24947688, PMCID: PMC4262725.
M.M.UndernerM.M. i inni, Cannabis et cancer bronchique, „Revue Des Maladies Respiratoires”, 31 (6), 2014, s. 488–498, DOI: 10.1016/j.rmr.2013.12.002, PMID: 25012035(fr.).
Donald P.D.P.TashkinDonald P.D.P., Effects of marijuana smoking on the lung, „Annals of the American Thoracic Society”, 10 (3), 2013, s. 239–247, DOI: 10.1513/AnnalsATS.201212-127FR, PMID: 23802821.
ManishM.JoshiManishM., AnitaA.JoshiAnitaA., ThaddeusT.BartterThaddeusT., Marijuana and lung diseases, „Current Opinion in Pulmonary Medicine”, 20 (2), 2014, s. 173–179, DOI: 10.1097/MCP.0000000000000026, PMID: 24384575.
doi.org
Y.H. Huang, Z.F. Zhang, D.P. Tashkin, B. Feng i inni. An epidemiologic review of marijuana and cancer: an update. „Cancer Epidemiol Biomarkers Prev”. 24 (1), s. 15–31, Jan 2015. DOI: 10.1158/1055-9965.EPI-14-1026. PMID: 25587109.
Portenoy, Russell K.; Ganae-Motan, Elena Doina; Allende, Silvia; Yanagihara, Ronald; Shaiova, Lauren; Weinstein, Sharon; McQuade, Robert; Wright, Stephen; Fallon, Marie T. (2012-05-01). „Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial”. The Journal of Pain. 13 (5): 438–449. doi:10.1016/j.jpain.2012.01.003. ISSN 1528-8447. PMID 22483680.
Jarosław Kosiaty (Akademia Medyczna w Warszawie): Narkotyki i Ty. narkotyk.co. [dostęp 2010-10-27]. [zarchiwizowane z tego adresu (2015-02-15)]. (pol.).
D’SouzaD.’S.DCD’SouzaD.’S., SewellS.RASewellS., RanganathanR.MRanganathanR., Cannabis and psychosis/schizophrenia: human studies, „European Archives of Psychiatry and Clinical Neuroscience”, 259 (7), 2009, s. 413–31, DOI: 10.1007/s00406-009-0024-2, PMID: 19609589, PMCID: PMC2864503.
CrippaC.JACrippaC. i inni, Cannabis and anxiety: a critical review of the evidence, „Human Psychopharmacology”, 24 (7), 2009, s. 515–23, DOI: 10.1002/hup.1048, PMID: 19693792.
F MarkusF.M.LewekeF MarkusF.M. i inni, Therapeutic Potential of Cannabinoids in Psychosis, „Biological Psychiatry”, 79 (7), 2016, s. 604–12, DOI: 10.1016/j.biopsych.2015.11.018, PMID: 26852073, Cytat: Epidemiological data indicate a strong relationship between cannabis use and psychosis and schizophrenia beyond transient intoxication with an increased risk of any psychotic outcome in individuals who had ever used cannabis.
MBM.Ortiz-MedinaMBM. i inni, Cannabis consumption and psychosis or schizophrenia development, „The International Journal of Social Psychiatry”, 64 (7), 2018, s. 690–704, DOI: 10.1177/0020764018801690, PMID: 30442059, Cytat: Cannabis use doubles the risk of developing psychosis in vulnerable people..
CharlesCh.KsirCharlesCh., Carl L.C.L.HartCarl L.C.L., Cannabis and Psychosis: a Critical Overview of the Relationship, „Current Psychiatry Reports”, 18 (2), 2016, s. 12, DOI: 10.1007/s11920-015-0657-y, PMID: 26781550.
GabriellaG.AvielloGabriellaG. i inni, Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer., „Journal of Molecular Medicine”, 90 (8), US National Library of Medicine. National Institutes of Health, 2012, s. 925–934, DOI: 10.1007/s00109-011-0856-x, PMID: 22231745 [dostęp 2013-02-20](ang.).
Jeremy R.J.R.JohnsonJeremy R.J.R. i inni, An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics, „Journal of Pain and Symptom Management”, 46 (2), 2013, s. 207–218, DOI: 10.1016/j.jpainsymman.2012.07.014, ISSN1873-6513, PMID: 23141881, OCLC818882612.
Shaheen ES.E.LakhanShaheen ES.E., MarieM.RowlandMarieM., Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review, „BMC Neurology”, 9 (59), 2009, DOI: 10.1186/1471-2377-9-59, PMID: 19961570, PMCID: PMC2793241.
Barbara S.B.S.KoppelBarbara S.B.S. i inni, Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology, „Neurology”, 82 (17), 2014, s. 1556–1563, DOI: 10.1212/WNL.0000000000000363, ISSN1526-632X, PMID: 24778283, PMCID: PMC4011465, OCLC960771045.
Amir H.A.H.SamAmir H.A.H., VictoriaV.SalemVictoriaV., Mohammad A.M.A.GhateiMohammad A.M.A., Rimonabant: From RIO to Ban, „Journal of Obesity”, 2011, DOI: 10.1155/2011/432607, PMID: 21773005, PMCID: PMC3136184 [dostęp 2020-04-15].
RafaelR.MaldonadoRafaelR., OlgaO.ValverdeOlgaO., Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses, „European Neuropsychopharmacology”, 13 (6), 2003, s. 401–410, DOI: 10.1016/j.euroneuro.2003.08.001, PMID: 14636956.
J.E.J.E.ThistleJ.E.J.E. i inni, Marijuana use and serum testosterone concentrations among U.S. males, „Andrology”, 5 (4), 2017, s. 732–738, DOI: 10.1111/andr.12358, PMID: 28395129, PMCID: PMC5660879(ang.).
HaroldH.KalantHaroldH., Adverse effects of cannabis on health: an update of the literature since 1996, „Progress in Neuro-Psychopharmacology & Biological Psychiatry”, 28 (5), 2004, s. 849–863, DOI: 10.1016/j.pnpbp.2004.05.027, PMID: 15363608.
S.H.S.H.BarskyS.H.S.H. i inni, Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco, „Journal of the National Cancer Institute”, 90 (16), 1998, s. 1198–1205, DOI: 10.1093/jnci/90.16.1198, PMID: 9719080.
Li RitaL.R.ZhangLi RitaL.R. i inni, Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium, „International Journal of Cancer”, 136 (4), 2015, s. 894–903, DOI: 10.1002/ijc.29036, PMID: 24947688, PMCID: PMC4262725.
M.M.UndernerM.M. i inni, Cannabis et cancer bronchique, „Revue Des Maladies Respiratoires”, 31 (6), 2014, s. 488–498, DOI: 10.1016/j.rmr.2013.12.002, PMID: 25012035(fr.).
Donald P.D.P.TashkinDonald P.D.P., Effects of marijuana smoking on the lung, „Annals of the American Thoracic Society”, 10 (3), 2013, s. 239–247, DOI: 10.1513/AnnalsATS.201212-127FR, PMID: 23802821.
Y.H. Huang, Z.F. Zhang, D.P. Tashkin, B. Feng i inni. An epidemiologic review of marijuana and cancer: an update. „Cancer Epidemiol Biomarkers Prev”. 24 (1), s. 15–31, Jan 2015. DOI: 10.1158/1055-9965.EPI-14-1026. PMID: 25587109.
ManishM.JoshiManishM., AnitaA.JoshiAnitaA., ThaddeusT.BartterThaddeusT., Marijuana and lung diseases, „Current Opinion in Pulmonary Medicine”, 20 (2), 2014, s. 173–179, DOI: 10.1097/MCP.0000000000000026, PMID: 24384575.
American College of Obstetricians Gynecologists Committee on Obstetric Practice (July 2015). „Committee Opinion No. 637: Marijuana Use During Pregnancy and Lactation”. Obstetrics and Gynecology. 126 (1): 234–8. doi:10.1097/01.AOG.0000467192.89321.a6. PMID 26241291.
Borgelt LM, Franson KL, Nussbaum AM, Wang GS (February 2013). „The pharmacologic and clinical effects of medical cannabis” (PDF). Pharmacotherapy. 33 (2): 195–209. doi:10.1002/phar.1187. PMID 23386598.
Bowles DW, O’Bryant CL, Camidge DR, Jimeno A (July 2012). „The intersection between cannabis and cancer in the United States”. Critical Reviews in Oncology/Hematology (Review). 83 (1): 1–10. doi:10.1016/j.critrevonc.2011.09.008. PMID 22019199.
Jordan K, Sippel C, Schmoll HJ (September 2007). „Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations”. The Oncologist (Review). 12 (9): 1143–50. doi:10.1634/theoncologist.12-9-1143. PMID 17914084.
Nicolson SE, Denysenko L, Mulcare JL, Vito JP, Chabon B (May–June 2012). „Cannabinoid hyperemesis syndrome: a case series and review of previous reports”. Psychosomatics (Review, case series). 53 (3): 212–9. doi:10.1016/j.psym.2012.01.003. PMID 22480624.
Portenoy, Russell K.; Ganae-Motan, Elena Doina; Allende, Silvia; Yanagihara, Ronald; Shaiova, Lauren; Weinstein, Sharon; McQuade, Robert; Wright, Stephen; Fallon, Marie T. (2012-05-01). „Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial”. The Journal of Pain. 13 (5): 438–449. doi:10.1016/j.jpain.2012.01.003. ISSN 1528-8447. PMID 22483680.
Lutge EE, Gray A, Siegfried N (April 2013). „The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS”. The Cochrane Database of Systematic Reviews (Review). 4 (4): CD005175. doi:10.1002/14651858.CD005175.pub3. PMID 23633327.
American College of Obstetricians Gynecologists Committee on Obstetric Practice (July 2015). „Committee Opinion No. 637: Marijuana Use During Pregnancy and Lactation”. Obstetrics and Gynecology. 126 (1): 234–8. doi:10.1097/01.AOG.0000467192.89321.a6. PMID 26241291.
Carter GT, Flanagan AM, Earleywine M, Abrams DI, Aggarwal SK, Grinspoon L (August 2011). „Cannabis in palliative medicine: improving care and reducing opioid-related morbidity”. The American Journal of Hospice & Palliative Care (Review). 28 (5): 297–303. doi:10.1177/1049909111402318. PMID 21444324.
sciencedirect.com
Bowles DW, O’Bryant CL, Camidge DR, Jimeno A (July 2012). „The intersection between cannabis and cancer in the United States”. Critical Reviews in Oncology/Hematology (Review). 83 (1): 1–10. doi:10.1016/j.critrevonc.2011.09.008. PMID 22019199.
Nicolson SE, Denysenko L, Mulcare JL, Vito JP, Chabon B (May–June 2012). „Cannabinoid hyperemesis syndrome: a case series and review of previous reports”. Psychosomatics (Review, case series). 53 (3): 212–9. doi:10.1016/j.psym.2012.01.003. PMID 22480624.
Jarosław Kosiaty (Akademia Medyczna w Warszawie): Narkotyki i Ty. narkotyk.co. [dostęp 2010-10-27]. [zarchiwizowane z tego adresu (2015-02-15)]. (pol.).
Portenoy, Russell K.; Ganae-Motan, Elena Doina; Allende, Silvia; Yanagihara, Ronald; Shaiova, Lauren; Weinstein, Sharon; McQuade, Robert; Wright, Stephen; Fallon, Marie T. (2012-05-01). „Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial”. The Journal of Pain. 13 (5): 438–449. doi:10.1016/j.jpain.2012.01.003. ISSN 1528-8447. PMID 22483680.
Jeremy R.J.R.JohnsonJeremy R.J.R. i inni, An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics, „Journal of Pain and Symptom Management”, 46 (2), 2013, s. 207–218, DOI: 10.1016/j.jpainsymman.2012.07.014, ISSN1873-6513, PMID: 23141881, OCLC818882612.
Barbara S.B.S.KoppelBarbara S.B.S. i inni, Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology, „Neurology”, 82 (17), 2014, s. 1556–1563, DOI: 10.1212/WNL.0000000000000363, ISSN1526-632X, PMID: 24778283, PMCID: PMC4011465, OCLC960771045.
W.W.HallW.W., L.L.DegenhardtL.L., M.M.LynskeyM.M., The health and psychological effects of cannabis use, National Drug and Alcohol Research Centre University of New South Wales, 2001 (Monograph Series No. 44), s. 73, ISSN1322-5049(ang.).
